ZyVersa Therapeutics, Inc. (ZVSA)
NASDAQ: ZVSA · Real-Time Price · USD
0.6700
-0.0300 (-4.29%)
At close: Jul 3, 2025, 1:00 PM
0.6705
+0.0005 (0.07%)
After-hours: Jul 3, 2025, 4:59 PM EDT
ZyVersa Therapeutics Market Cap
ZyVersa Therapeutics has a market cap or net worth of $3.27 million as of July 3, 2025. Its market cap has decreased by -25.51% in one year.
Market Cap
3.27M
Enterprise Value
1.65M
1-Year Change
-25.51%
Ranking
Category
Stock Price
$0.67
Market Cap Chart
Since February 10, 2022, ZyVersa Therapeutics's market cap has decreased from $95.47M to $3.27M, a decrease of -96.58%. That is a compound annual growth rate of -63.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2025 | 3.27M | 22.81% |
| Dec 31, 2024 | 2.66M | -43.66% |
| Dec 29, 2023 | 4.72M | -66.90% |
| Dec 30, 2022 | 14.26M | -85.07% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 700.84B |
| Johnson & Johnson | 375.37B |
| AbbVie | 334.34B |
| Novo Nordisk | 306.47B |
| UnitedHealth Group | 279.90B |
| Novartis AG | 238.56B |
| Abbott Laboratories | 233.90B |
| AstraZeneca | 216.08B |